Reduce Inefficiencies in Management of Spasticity
ConditionStroke
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorThe University of Texas Health Science Center, Houston
About this trial
The purpose of this study is to evaluate the effectiveness of a spasticity screener and to determine if the spasticity screener results are useful to healthcare providers and impact clinical decision making
Eligibility criteria
Qualifiers
Currently admitted for an acute hemorrhagic or ischemic stroke; recurrent stroke allowed if no spasticity at baseline
NIHSS score of > 0 on items 5 or 6 (required of at least 1 limb)
Willingness to participate in the study for 24 months
Able to sign consent form or availability of a legally authorized representative to sign
Disqualifiers
Botulinum toxin use for any indication within the past 12 weeks
Acute life threatening illness
Prior limb injury or neurological diagnosis that limited movement in the now affected limb(s)
Any terminal illness that would limit participation in study follow ups
Trial design
Treatments tested in this trial
- Screener
- Standard of care
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
The University of Texas Health Science Center, Houston
Lead sponsor
AbbVie
Collaborator
Source ClinicalTrials.gov